信立泰: 关于控股股东部分股份解除质押的公告

Core Viewpoint - Shenzhen Xinlitai Pharmaceutical Co., Ltd. announced the completion of the release of pledged shares held by its controlling shareholder, Hong Kong Xinlitai Pharmaceutical Co., Ltd., which will not affect the company's operations or governance [1][3]. Group 1: Share Pledge Release - The controlling shareholder, Hong Kong Xinlitai, released 15,679,000 shares, accounting for 2.36% of its total holdings and 1.35% of the company's total shares [1]. - After the release, the total number of pledged shares held by the controlling shareholder is 11,400,000 shares, which represents 17.94% of its total holdings and 10.23% of the company's total shares [3]. Group 2: Shareholder Information - The total shares held by Hong Kong Xinlitai amount to 63,527,938 shares, representing 56.99% of the company's total shares [2]. - The company confirms that there are no other shareholders holding more than 5% of the company's shares that are currently pledged [3].